Pfizer posts FY2023 revenue $58.5B, adj EPS $1.84; reaffirms FY2024 guidance

PFIZER INC

2023-FY EPS reported $0.37 revenue$58,496,000,000

Full-year 2023 revenues $58.5B, down 41% operationally; reported diluted EPS $0.37, down 93%; adjusted diluted EPS $1.84, down 72%.
Q4 2023 revenues $14.2B, down 42% operationally; reported diluted LPS $(0.60), adjusted EPS $0.10.
Ex-COVID products grew 7% operationally in FY2023 (8% in Q4); Seagen acquisition closed Dec 2023 for $44B.
FY2024 revenue guidance $58.5-61.5B, adj EPS $2.05-2.25; expects $4B cost savings by end 2024.
No share repurchases planned in 2024; $9.2B dividends paid in FY2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PFIZER INC reported full-year 2024 results: revenue $58.5 to $61.5 Billion, EPS $2.05 to $2.25. Guidance reaffirmed.

Period: full-year 2024
Revenue: $58.5 to $61.5 Billion
EPS: $2.05 to $2.25
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Annual Net Cost Savings by End of 2024 from Previously Announced Cost Realignment Program ▪ Reaffirms Full-Year 2024 Guidance (5) Provided on December 13, 2023, of Revenues of $58.5 to $61.5 Billion and Adjusted (3) Diluted EPS of $2.05 to $2.25 NEW YORK, Tuesday, January 30, 2024 — Pfizer Inc. (NYSE: PFE) reported financial results for fourth quarter and

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PFIZER INC reported fourth-quarter 2023 results: revenue $14.2 Billion, net income ($3,369) million, EPS ($0.60).

Period: fourth-quarter 2023
Revenue: $14.2 Billion
Net income: ($3,369) million
EPS: ($0.60)
Result: reported results

Exact text from the filing

$0.37, Down 93% Year-Over-Year, and Adjusted (3) Diluted EPS of $1.84, Down 72% Year-Over-Year, Significantly Impacted by One-Time Events (4) ▪ Fourth-Quarter 2023 Revenues of $14.2 Billion – Expected Decline in Comirnaty (1) and Paxlovid Revenues Drove 42% Operational Decrease in Fourth-Quarter Revenues – Excluding Contributions from Comirnaty (1) and Paxlovid,

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PFIZER INC reported full-year 2023 results: revenue $58.5 Billion, net income $2,119 million, EPS $0.37.

Period: full-year 2023
Revenue: $58.5 Billion
Net income: $2,119 million
EPS: $0.37
Result: reported results

Exact text from the filing

Launched Significant Number of New Products and Indications; and Realigned Commercial Organization to Improve Focus, Speed and Execution ▪ Full-Year 2023 Revenues of $58.5 Billion – Expected Decline in Comirnaty (1) and Paxlovid Revenues Drove 41% Operational Decrease in Year-Over-Year Revenues – Excluding Contributions from Comirnaty (1) and Paxlovid,

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

PFIZER INC filing history →

Source: SEC EDGAR

accession 0000078003-24-000017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.